RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
MeiraGTx Holdings Stock

MeiraGTx Holdings ROCE 2024

MeiraGTx Holdings ROCE

-0.99

Ticker

MGTX

ISIN

KYG596651029

WKN

A2JGHF

In 2024, MeiraGTx Holdings's return on capital employed (ROCE) was -0.99, a 0.33% increase from the -0.99 ROCE in the previous year.

MeiraGTx Holdings Aktienanalyse

What does MeiraGTx Holdings do?

MeiraGTx Holdings PLC is a leading company in the field of gene therapy and develops innovative therapies for various genetic diseases. The company was founded in 2015 and is headquartered in London, UK, with additional locations in the USA. MeiraGTx aims to change lives by developing gene therapy-based drugs that enable a cure or permanent relief from serious illnesses. History: MeiraGTx was founded by renowned genome researcher Dr. Gregory A. Petsko and an experienced team of scientists and experts in the biotechnology and pharmaceutical fields. With an experienced team and significant investment capital, MeiraGTx has established itself as a leading company in the field of gene therapy. Business model: MeiraGTx has a unique business model based on an innovative platform technology that enables the company to develop gene therapies for various diseases. The company works with a variety of technologies, including AAV vectors, DNA targeted integration, gene editing platform, and more. By combining these technologies, MeiraGTx can develop gene therapies tailored to the individual's condition. Segments: MeiraGTx consists of various divisions and products that focus on the development of therapeutics for various genetic diseases. Ophthalmology: MeiraGTx develops gene therapies for retinal diseases such as retinitis pigmentosa and macular degeneration. These therapies have the potential to preserve or even improve vision. Neurology: MeiraGTx develops therapeutics for neurological diseases such as Parkinson's and Huntington's. These gene therapies have the potential to alleviate the symptoms of the disease and improve the patient's quality of life. Hemophilia: MeiraGTx has developed gene therapies for hemophilia A and B based on its gene editing platform technology. These therapies have the potential to significantly improve the lives of hemophilia patients. Other products and therapies: MeiraGTx is also working on the development of gene therapies for cancer, cystic fibrosis, cardiovascular diseases, and autoimmune diseases. Summary: MeiraGTx is a leading company in the field of gene therapy and is committed to developing innovative therapeutics for various genetic diseases. With the help of technologies such as AAV vectors, DNA targeted integration, gene editing platform, and more, the company has the potential to change the lives of millions of patients. MeiraGTx is on track to revolutionize the healthcare industry, and it will be exciting to see what future advances the company will achieve. MeiraGTx Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling MeiraGTx Holdings's Return on Capital Employed (ROCE)

MeiraGTx Holdings's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing MeiraGTx Holdings's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

MeiraGTx Holdings's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in MeiraGTx Holdings’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about MeiraGTx Holdings stock

What is the ROCE (Return on Capital Employed) of MeiraGTx Holdings this year?

The ROCE of MeiraGTx Holdings is -0.99 undefined this year.

How has the ROCE (Return on Capital Employed) of MeiraGTx Holdings developed compared to the previous year?

The ROCE of MeiraGTx Holdings has increased by 0.33% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of MeiraGTx Holdings?

A high Return on Capital Employed (ROCE) indicates that MeiraGTx Holdings has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of MeiraGTx Holdings?

A low ROCE (Return on Capital Employed) can indicate that MeiraGTx Holdings has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from MeiraGTx Holdings impact the company?

An increase in the ROCE of MeiraGTx Holdings can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of MeiraGTx Holdings affect the company?

A decrease in ROCE of MeiraGTx Holdings can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of MeiraGTx Holdings?

Some factors that can affect MeiraGTx Holdings's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of MeiraGTx Holdings so important for investors?

The ROCE of MeiraGTx Holdings is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can MeiraGTx Holdings take to improve the ROCE?

To improve the ROCE, MeiraGTx Holdings can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does MeiraGTx Holdings pay?

Over the past 12 months, MeiraGTx Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, MeiraGTx Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of MeiraGTx Holdings?

The current dividend yield of MeiraGTx Holdings is .

When does MeiraGTx Holdings pay dividends?

MeiraGTx Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of MeiraGTx Holdings?

MeiraGTx Holdings paid dividends every year for the past 0 years.

What is the dividend of MeiraGTx Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is MeiraGTx Holdings located?

MeiraGTx Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von MeiraGTx Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of MeiraGTx Holdings from 9/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/20/2024.

When did MeiraGTx Holdings pay the last dividend?

The last dividend was paid out on 9/20/2024.

What was the dividend of MeiraGTx Holdings in the year 2023?

In the year 2023, MeiraGTx Holdings distributed 0 USD as dividends.

In which currency does MeiraGTx Holdings pay out the dividend?

The dividends of MeiraGTx Holdings are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von MeiraGTx Holdings

Our stock analysis for MeiraGTx Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MeiraGTx Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.